Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Di
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NAS: CSII) , announced today that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
About Cardiovascular Systems, Inc.Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating ...
New York, July 25, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Laser Atherectomy Devices Global Market Report 2023" - https://www ...
Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...
Austin, United States, Aug. 05, 2026 (GLOBE NEWSWIRE) -- The Atherectomy Devices Market Size was valued at USD 0.94 Billion in 2025 and is projected to reach USD 1.90 Billion by 2035, growing at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results